Add Yahoo as a preferred source to see more of our stories on Google. When we think of movement disorders, the tremors associated with Parkinson’s disease are probably what first spring to mind.
Jonathan Allen first picked up the trombone in the fourth grade. After playing for years, he eventually earned a doctorate in musical arts and a teaching position at the University of Iowa. Then, one ...
New $40 million raise brings Series A total to $100M, enabling advancement of VIM0423, a first-in-class oral therapeutic, into Phase 2 trials for ...
A recent grant award in the Department of Neurology serves to help investigators analyze how a group of brain cells may be responsible for changes to neural circuits that lead to the movement disorder ...
Despite modern high-throughput sequencing, the genetic cause of most rare movement disorders remains unclear. A research team ...
Incubated by Atlas Venture, the biotech startup is advancing a daily pill it sees potentially helping people with dystonia or ...
MICKLETON, N.J. (WPVI) -- Nearly everyone gets a muscle cramp from time to time. When muscle contractions won't stop and can't be controlled, that's called dystonia. A South Jersey man is now sharing ...
KNOXVILLE, Tenn. (WATE) — September is National Dystonia Awareness Month. Dystonia is a chronic movement disorder affecting the brain and nervous system. If you are like a lot of people, you might not ...
Oct. 14 (UPI) --A new award will help early career researchers who study dystonia, the Michael J. Fox Foundation announced Tuesday. The new Bachmann-Strauss Early Career Award is a two-year, $150,000 ...
Pharmaceutical Technology on MSN
Vima banks $100m in Series A to progress Parkinson’s drug
The selective muscarinic agonist is now in mid-stage development for movement disorders like Parkinson’s disease and dystonia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results